nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment of fracture risk: Who should be treated for osteoporosis?
|
van der Klift, M. |
|
2005 |
19 |
6 |
p. 937-950 14 p. |
artikel |
2 |
Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates
|
Romas, Evan |
|
2005 |
19 |
6 |
p. 1065-1079 15 p. |
artikel |
3 |
Corrigendum to “How to prevent low back pain” [Best Practice & Research Clinical Rheumatology 19 (2005) 541–555]
|
Kim Burton, A. |
|
2005 |
19 |
6 |
p. 1095- 1 p. |
artikel |
4 |
Determinants of skeletal fragility
|
Bouxsein, Mary L. |
|
2005 |
19 |
6 |
p. 897-911 15 p. |
artikel |
5 |
Editorial Board/Aims and Scope
|
|
|
2005 |
19 |
6 |
p. iii- 1 p. |
artikel |
6 |
How many people develop fractures with what outcome?
|
O'Neill, Terence W. |
|
2005 |
19 |
6 |
p. 879-895 17 p. |
artikel |
7 |
How to manage osteoporosis after the menopause
|
Compston, Juliet |
|
2005 |
19 |
6 |
p. 1007-1019 13 p. |
artikel |
8 |
How to manage osteoporosis in children
|
Bianchi, Maria Luisa |
|
2005 |
19 |
6 |
p. 991-1005 15 p. |
artikel |
9 |
Index
|
|
|
2005 |
19 |
6 |
p. I1- 1 p. |
artikel |
10 |
In whom and how to prevent glucocorticoid-induced osteoporosis
|
Adachi, Jonathan D. |
|
2005 |
19 |
6 |
p. 1039-1064 26 p. |
artikel |
11 |
Newer drug treatments: Their effects on fracture prevention
|
Geusens, Piet |
|
2005 |
19 |
6 |
p. 983-989 7 p. |
artikel |
12 |
[No title]
|
Geusens, Piet P.M.M. |
|
2005 |
19 |
6 |
p. vii- 1 p. |
artikel |
13 |
Setting up an osteoporosis fracture liaison service: background and potential outcomes
|
Gallacher, Stephen J. |
|
2005 |
19 |
6 |
p. 1081-1094 14 p. |
artikel |
14 |
The management of secondary osteoporosis
|
Kelman, Ariella |
|
2005 |
19 |
6 |
p. 1021-1037 17 p. |
artikel |
15 |
What is the role of DXA, QUS and bone markers in fracture prediction, treatment allocation and monitoring?
|
Briot, Karine |
|
2005 |
19 |
6 |
p. 951-964 14 p. |
artikel |
16 |
What is the role of falls?
|
Close, Jacqueline C.T. |
|
2005 |
19 |
6 |
p. 913-935 23 p. |
artikel |
17 |
Who will benefit from antiresorptive treatment (bisphosphonates)?
|
Papapoulos, Socrates E. |
|
2005 |
19 |
6 |
p. 965-973 9 p. |
artikel |
18 |
Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?
|
Sambrook, Philip |
|
2005 |
19 |
6 |
p. 975-981 7 p. |
artikel |